Patents by Inventor Justin A. MacDonald

Justin A. MacDonald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240279234
    Abstract: The present disclosure is directed to compounds that may selectively inhibit Death Associated Protein Kinases (DAPKs) as well as PIM kinases. The compounds can be used in methods of treating various disorders, including cancers.
    Type: Application
    Filed: April 24, 2024
    Publication date: August 22, 2024
    Inventors: Timothy A.J. Haystead, David A. Carlson, Douglas H. Weitzel, Justin A. MacDonald, Michael P. Walsh
  • Patent number: 11999737
    Abstract: The present disclosure is directed to compounds that may selectively inhibit Death Associated Protein Kinases (DAPKs) as well as PIM kinases. The compounds can be used in methods of treating various disorders, including cancers.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: June 4, 2024
    Assignee: Duke University
    Inventors: Timothy A. J. Haystead, David A. Carlson, Douglas H. Weitzel, Justin A. MacDonald, Michael P. Walsh
  • Publication number: 20210155627
    Abstract: The present disclosure is directed to compounds that may selectively inhibit Death Associated Protein Kinases (DAPKs) as well as PIM kinases. The compounds can be used in methods of treating various disorders, including cancers.
    Type: Application
    Filed: February 2, 2021
    Publication date: May 27, 2021
    Inventors: Timothy A. J. Haystead, David A. Carlson, Douglas H. Weitzel, Justin A. MacDonald, Michael P. Walsh
  • Patent number: 10934291
    Abstract: The present disclosure is directed to compounds that may selectively inhibit Death Associated Protein Kinases (DAPKs) as well as PIM kinases. The compounds can be used in methods of treating various disorders, including cancers.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: March 2, 2021
    Assignees: Duke University, UTI Limited Partnership
    Inventors: Timothy A. J. Haystead, David A. Carlson, Douglas H. Weitzel, Justin A. MacDonald, Michael P. Walsh
  • Publication number: 20170260191
    Abstract: The present disclosure is directed to compounds that may selectively inhibit Death Associated Protein Kinases (DAPKs) as well as PIM kinases. The compounds can be used in methods of treating various disorders, including cancers.
    Type: Application
    Filed: September 25, 2015
    Publication date: September 14, 2017
    Inventors: Timothy A. J. Haystead, David A. Carlson, Douglas H. Weitzel, Justin A. MacDonald, Michael P. Walsh